InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by Johnson Craig A, Director. Director active across 2 companies, notably Heron Therapeutics, INC.. Aggregated, 8 reports have been recorded. Total volume traded: €16k. The latest transaction was disclosed on 14 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
02,546 shares0
Common Stock
SEC:0001214659-22-000846·
02,546 shares0
Common Stock
SEC:0001214659-22-000846:0·
€2,156250 shares@ €8.62570.0009% mcap27.1% of flow
Common Stock
SEC:0001209191-21-071169·
€2,156250 shares@ €8.62570.0009% mcap13.5% of flow
Common Stock
SEC:0001209191-21-071169:0·
€2,622250 shares@ €10.48920.0011% mcap32.9% of flow
Common Stock
SEC:0001209191-21-057419·
€2,622250 shares@ €10.48920.0011% mcap16.5% of flow
Common Stock
SEC:0001209191-21-057419:0·
€3,190250 shares@ €12.76170.0013% mcap40.0% of flow
Common Stock
SEC:0001209191-21-042429·
€3,190250 shares@ €12.76170.0013% mcap20.0% of flow
Common Stock
SEC:0001209191-21-042429:0·
8 of 8 declarations
About Johnson Craig A
Craig A. Johnson is a Board Member at HERON THERAPEUTICS, INC. and Mirati Therapeutics, Inc. He contributes to the strategic direction of these companies, participating in key decisions that influence their development. His expertise in the biopharmaceutical sector is valuable to the boards, enabling these companies to navigate effectively in a competitive environment.
